Frequently Asked Questions
1. How does Microimmunotherapy differ from standard medication?
Conventional medicine often suppresses the immune response. MIT retrains it — restoring proper signaling and balance.
2. Is it safe?
Yes. Because it uses ultra-low physiological doses, it’s exceptionally safe and free of toxicity.
3. Who can benefit?
Anyone dealing with immune imbalance — from chronic fatigue to autoimmune conditions and viral reactivation.
4. Can it be combined with other therapies?
Absolutely. It’s designed to work synergistically with IV therapy, peptides, detox, and hormonal optimization.
5. How long does therapy last?
Treatment is personalized, typically lasting several weeks to months depending on your immune pattern.
6. Are there side effects?
Very few. Some patients may feel temporary fatigue or mild immune activation, a sign of adjustment.
7. Is it suitable for all ages?
Yes. Its gentle nature makes it safe for both younger and older patients.
8. Do I need laboratory tests first?
Yes. Immune and inflammatory markers guide protocol design for precision treatment.
9. How is it administered?
Usually as small oral capsules that dissolve under the tongue. Dosing sequences are tailored during consultation.
10. When will I notice results?
Most patients feel increased energy or improved resilience within weeks, though full immune rebalancing may take several months.